These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15878634)

  • 21. Targeting the innate immune response with improved vaccine adjuvants.
    Pashine A; Valiante NM; Ulmer JB
    Nat Med; 2005 Apr; 11(4 Suppl):S63-8. PubMed ID: 15812492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended recombinant bacterial ghost system.
    Lubitz W; Witte A; Eko FO; Kamal M; Jechlinger W; Brand E; Marchart J; Haidinger W; Huter V; Felnerova D; Stralis-Alves N; Lechleitner S; Melzer H; Szostak MP; Resch S; Mader H; Kuen B; Mayr B; Mayrhofer P; Geretschläger R; Haslberger A; Hensel A
    J Biotechnol; 1999 Aug; 73(2-3):261-73. PubMed ID: 10486935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR; Letvin NL
    Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.
    Friede M; Aguado MT
    Adv Drug Deliv Rev; 2005 Jan; 57(3):325-31. PubMed ID: 15560944
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of attenuated bacteria as delivery vectors for DNA vaccines.
    Daudel D; Weidinger G; Spreng S
    Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses.
    Kammer AR; Amacker M; Rasi S; Westerfeld N; Gremion C; Neuhaus D; Zurbriggen R
    Vaccine; 2007 Oct; 25(41):7065-74. PubMed ID: 17766014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adjuvants--essential components of new generation vaccines].
    Dzierzbicka K; Kołodziejczyk AM
    Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
    Anderson RJ; Schneider J
    Vaccine; 2007 Sep; 25 Suppl 2():B24-34. PubMed ID: 17698262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA vaccines for biodefence.
    Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular adjuvants for malaria DNA vaccines based on the modulation of host-cell apoptosis.
    Bergmann-Leitner ES; Leitner WW; Duncan EH; Savranskaya T; Angov E
    Vaccine; 2009 Sep; 27(41):5700-8. PubMed ID: 19576940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for DNA vaccine delivery.
    Alpar HO; Papanicolaou I; Bramwell VW
    Expert Opin Drug Deliv; 2005 Sep; 2(5):829-42. PubMed ID: 16296781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattle.
    van Drunen Littel-van den Hurk S; Luxembourg A; Ellefsen B; Wilson D; Ubach A; Hannaman D; van den Hurk JV
    Vaccine; 2008 Oct; 26(43):5503-9. PubMed ID: 18708108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Listeria monocytogenes as novel carrier system for the development of live vaccines.
    Schoen C; Loeffler DI; Frentzen A; Pilgrim S; Goebel W; Stritzker J
    Int J Med Microbiol; 2008 Jan; 298(1-2):45-58. PubMed ID: 17936682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficiency of a novel delivery system (PEI600-Tat) in development of potent DNA vaccine using HPV16 E7 as a model antigen.
    Bolhassani A; Ghasemi N; Servis C; Taghikhani M; Rafati S
    Drug Deliv; 2009 May; 16(4):196-204. PubMed ID: 19514980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice.
    Voltan R; Castaldello A; Brocca-Cofano E; De Michele R; Triulzi C; Altavilla G; Tondelli L; Laus M; Sparnacci K; Reali E; Gavioli R; Ensoli B; Caputo A
    Vaccine; 2009 Jul; 27(33):4498-507. PubMed ID: 19450649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial Ghosts as antigen and drug delivery system for ocular surface diseases: Effective internalization of Bacterial Ghosts by human conjunctival epithelial cells.
    Kudela P; Koller VJ; Mayr UB; Nepp J; Lubitz W; Barisani-Asenbauer T
    J Biotechnol; 2011 May; 153(3-4):167-75. PubMed ID: 21501636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple whole bacterial antigens in polyvalent vaccine may result in inhibition of specific responses in rainbow trout (Oncorhynchus mykiss).
    Nikoskelainen S; Verho S; Järvinen S; Madetoja J; Wiklund T; Lilius EM
    Fish Shellfish Immunol; 2007 Mar; 22(3):206-17. PubMed ID: 16849036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosis.
    Vipond J; Clark SO; Hatch GJ; Vipond R; Marie Agger E; Tree JA; Williams A; Marsh PD
    Tuberculosis (Edinb); 2006; 86(3-4):218-24. PubMed ID: 16520093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A DNA vaccine strategy for effective antibody induction to pathogen-derived antigens.
    Rice J; Christodoulides M
    Methods Mol Biol; 2012; 799():405-19. PubMed ID: 21993657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.